1. Home
  2. MYGN vs FCBC Comparison

MYGN vs FCBC Comparison

Compare MYGN & FCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$7.09

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Logo First Community Bankshares Inc. (VA)

FCBC

First Community Bankshares Inc. (VA)

HOLD

Current Price

$32.62

Market Cap

612.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
FCBC
Founded
1991
1874
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
625.5M
612.1M
IPO Year
1995
1992

Fundamental Metrics

Financial Performance
Metric
MYGN
FCBC
Price
$7.09
$32.62
Analyst Decision
Hold
Analyst Count
13
0
Target Price
$12.58
N/A
AVG Volume (30 Days)
1.1M
37.3K
Earning Date
11-03-2025
01-27-2026
Dividend Yield
N/A
3.80%
EPS Growth
N/A
N/A
EPS
N/A
2.68
Revenue
$825,300,000.00
$164,262,000.00
Revenue This Year
$0.10
$2.27
Revenue Next Year
$5.28
$11.13
P/E Ratio
N/A
$12.17
Revenue Growth
0.21
0.67
52 Week Low
$3.76
$31.21
52 Week High
$16.63
$46.53

Technical Indicators

Market Signals
Indicator
MYGN
FCBC
Relative Strength Index (RSI) 47.96 46.11
Support Level $6.93 $32.69
Resistance Level $7.38 $33.93
Average True Range (ATR) 0.39 0.99
MACD 0.03 0.10
Stochastic Oscillator 39.88 47.55

Price Performance

Historical Comparison
MYGN
FCBC

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

About FCBC First Community Bankshares Inc. (VA)

First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.

Share on Social Networks: